CEBPA and acute myeloid leukemia: It's involvement in AML is diverse, with patients frequently exhibiting mutations, deregulation of gene expression or alterations in the function of C/EBPα.34 The down‐regulation of CRT by siRNA can increase the expression of C/EBPα.